EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Phase-resolved functional lung MRI detects single-dose and sustained bronchodilator responses in COPD in a randomized crossover trial

Andreas Voskrebenzev, Till F Kaireit, Marius M Klein, Agilo L Kern, Lea Behrendt, Filip Klimeš, Robin A Müller, Thomas Kayser, Frank Wacker, Jens Vogel-Claussen, Jens M Hohlfeld

European Radiology · 2026

DOI: 10.1007/s00330-026-12604-6 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Radiology, 2026. Verfasst von Andreas Voskrebenzev und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Magnetic Resonance Imaging, Lung. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Deutsches Zentrum für Lungenforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the effects of tiotropium/olodaterol (T/O) on phase-resolved functional lung (PREFUL) MRI parameters in hyperinflated chronic obstructive pulmonary disease (COPD) patients and examine correlations with conventional cardiopulmonary and hyperpolarized 129 Xe MRI measures. Materials and methods Retrospective subanalysis of a prospective, randomized, placebo-controlled, crossover trial with open-label extension. Thirty-two patients with moderate-to-severe COPD (61.5 ± 7.7 years; 17 men); 30 completed the MRI extension at 1.5 T. PREFUL analysis yielded regional ventilation (RVent), flow-volume loop correlation metric (FVL-CM), normalized perfusion (QN), ventilation defect percentage (VDP), perfusion defect percentage (QDP), V/Q match metrics (VQM), and pulmonary pulse wave velocity (PWV; post-hoc parameter). Linear mixed-effects models tested treatment effects; correlations were evaluated with Spearman’s rank and bootstrap 95% confidence intervals (95% CIs).

Results

PREFUL parameters improved after T/O single dose (SD) versus placebo, including improvements in FVL-CM by 4.1 percentage points (pp; 95% CI: 1.0 to 7.3 pp) and QN by 0.4 pp (95% CI: 0.2 to 0.6 pp) and reductions in VDP and QDP, with parallel gains in VQM(Non-Defect) ( p < 0.05). PWV decreased after multiple doses (−0.87 m/s, 95% CI: −1.26 to −0.48 m/s). PREFUL MRI baseline values showed significant correlations with pulmonary function tests, cardiac, dynamic contrast-enhanced and 129 Xe MRI. SD treatment-induced absolute changes in VDP(FVL-CM) correlated with reductions in residual volume ( ρ = 0.41, 95% CI: 0.02 to 0.64). Further correlations were observed between PREFUL MRI and ¹²⁹Xe-derived VDP, apparent diffusion coefficient, and compartment ratios.

Conclusion

PREFUL MRI sensitively captured immediate SD T/O-induced improvements in V/Q parameters and dose-dependent PWV responses after sustained bronchodilation. Key Points Question Can phase-resolved functional lung (PREFUL) MRI sensitively capture immediate single-dose and sustain multi-dose effects of tiotropium/olodaterol on ventilation-perfusion and vascular function in COPD patients?

Findings

Tiotropium/olodaterol improved PREFUL MRI-derived ventilation, perfusion, and V/Q matching parameters after a single dose, with sustained pulmonary vascular improvements after repeated dosing. Clinical relevance PREFUL MRI detected immediate and sustained functional improvements after tiotropium/olodaterol and showed significant correlations with cardiopulmonary tests and hyperpolarized ¹²⁹Xe MRI, supporting its role as a sensitive, radiation-free tool for monitoring COPD treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveBronchodilator AgentsMagnetic Resonance ImagingLungHumansCross-Over StudiesMaleTiotropium BromideMiddle AgedFemaleAgedTreatment OutcomeRetrospective StudiesProspective StudiesDrug CombinationsBenzoxazines

Stichwörter der Autor:innen

Bronchodilation, COPDFunctional pulmonary proton MRILungPREFUL

Substanzen

Bronchodilator AgentsTiotropium BromideDrug Combinationstiotropium-olodaterolBenzoxazines

Autor:innen und Institutionen

  • Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
  • Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Department of Diagnostic and Interventional Radiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.
  • Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany. jens.vogel-claussen@charite.de.
  • Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. jens.vogel-claussen@charite.de.

Förderung

  • Boehringer Ingelheim
  • Deutsches Zentrum für Lungenforschung

Zitieren

APA

Voskrebenzev, A., Kaireit, T. F., Klein, M. M., Kern, A. L., Behrendt, L., Klimeš, F., Müller, R. A., Kayser, T., Wacker, F., Vogel-Claussen, J., & Hohlfeld, J. M. (2026). Phase-resolved functional lung MRI detects single-dose and sustained bronchodilator responses in COPD in a randomized crossover trial. European Radiology. https://doi.org/10.1007/s00330-026-12604-6

Vancouver

Voskrebenzev A, Kaireit TF, Klein MM, Kern AL, Behrendt L, Klimeš F, et al. Phase-resolved functional lung MRI detects single-dose and sustained bronchodilator responses in COPD in a randomized crossover trial. European Radiology. 2026. doi:10.1007/s00330-026-12604-6

BibTeX
@article{Voskrebenzev2026,
  author = {Voskrebenzev, Andreas and Kaireit, Till F and Klein, Marius M and Kern, Agilo L and Behrendt, Lea and Klimeš, Filip and Müller, Robin A and Kayser, Thomas and Wacker, Frank and Vogel-Claussen, Jens and Hohlfeld, Jens M},
  title = {Phase-resolved functional lung MRI detects single-dose and sustained bronchodilator responses in COPD in a randomized crossover trial},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-026-12604-6}
}
Kostenlos starten →